Page last updated: 2024-08-23

dermatan sulfate and Hemorrhage

dermatan sulfate has been researched along with Hemorrhage in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (22.92)	18.7374
1990's	19 (39.58)	18.2507
2000's	12 (25.00)	29.6817
2010's	5 (10.42)	24.3611
2020's	1 (2.08)	2.80

Authors

Authors	Studies
Ashizawa, M; Fujiwara, SI; Hatano, K; Hayakawa, J; Ikeda, T; Ishihara, Y; Ito, S; Kanda, Y; Kawaguchi, SI; Kawasaki, Y; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakano, H; Nakasone, H; Ochi, SI; Oh, I; Ohmine, K; Ohmori, T; Sato, K; Sugimoto, M; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R	1
Banik, N; Beyer-Westendorf, J; Brachmann, J; Dohmen, PM; Eberle, S; Hankowitz, J; Klamroth, R; Kropff, S; Lindhoff-Last, E; Madlener, K; Müller, MM; Pötzsch, B; Schellong, S; Schindewolf, M; Steindl, J	1
Baumgarten, G; Kim, S; Koster, A; Riedel, R; Schewe, JC; Schmieder, A	1
Magnani, HN	2
Biesma, DH; Haas, FJ; Leusink, JA; Veth, G; Wester, JP	1
Kreutzenbeck, HJ; Lindhoff-Last, E; Magnani, HN	1
Bidlingmaier, C; Girisch, M; Kurnik, K; Magnani, HN	1
Fischer, KG	1
Ahmed, I; Majeed, A; Powell, R	1
Henny, CP; Ockelford, PA; Surachno, S; Ten Cate, H; Ten Cate, JW; van Bronswijk, H; Wilmink, JM	1
Bucknall, T; Cade, J; Gallus, A; Hepburn, S; Maas, M; Magnani, H; Ockelford, P; Porteous, F; Stevens, J	1
Borris, LC; Lassen, MR	1
Banga, JD; Brouwer, CB; de Valk, HW; Hart, HC; Meuwissen, OJ; Nieuwenhuis, HK; Sixma, JJ; van Hessen, MW; Wester, JW	1
Brister, SJ; Buchanan, MR; Gianese, F; Heigenhauser, GJ; Ofosu, FA	1
Cesmeli, S; Davies, AB; Gray, E; Lane, DA; Lormeau, JC	1
Banga, JD; Brouwer, CB; de Valk, HW; Hart, HC; Meuwissen, OJ; Nieuwenhuis, HK; Sixma, JJ; van der Graaf, Y; Wester, JP	1
Ofosu, FA	1
Byrne, JL; Cassidy, MJ; Haynes, AP; Roe, SD	1
Jang, IK; Januzzi, JL	1
Black, MD; Edgell, D; Leaker, MT; Noel, D; Saxon, BR	1
Cleland, AG; Fernandes, P; Hay-McKay, C; MacDonald, JL; Mayer, R	1
Eichler, P; Farner, B; Greinacher, A; Kroll, H	1
Corno, A; Horisberger, J; Marty, B; Mueller, X; von Segesser, LK	1
Bauersachs, R; Betz, C; Lindhoff-Last, E	1
Lecompte, T	1
Alves-Sá, R; Araújo, FS; Mourão, PA; Pavão, MS; Peixoto, LL; Vicente, CP; Zancan, P	1
Pavão, MS	1
Bergqvist, D	1
Meuleman, DG	2
Adams, HP; Biller, J; Clarke, W; Woolson, RF	1
Côte, R; Geerts, W; Gent, M; Ginsberg, JS; Jay, R; Leclerc, J; Levine, MN; Neemeh, J; Powers, PJ; Turpie, AG	1
Cuppini, S; Gianese, F; Maffei Faccioli, A; Meduri, F; Polistena, P; Prandoni, P; Toniato, A; Zangrandi, F	1
Bergqvist, D; Cederholm, C; Faunø, P; Fredin, H; Jensen, LJ; Justesen, T; Karjalainen, P; Kettunen, K; Soimakallio, S; Suomalainen, O	1
Fareed, J; Hoppensteadt, D; Nurmohamed, MT; ten Cate, JW; Walenga, JM	1
Fareed, J; Hoppensteadt, D; Walenga, JM	1
Adams, HP; Alberts, M; Biller, J; Bruno, A; Davis, JN; Goldstein, LB; Marler, JR; Massey, EW	1
Adams, HP; Alberts, M; Biller, J; Bruno, A; Davis, JN; Goldstein, LB; Henriksen, RA; Linhardt, RJ; Marler, JR; Massey, EW	1
Gallus, A; Magnani, H; Marshall, V; Morris, M; Murphy, W; Nacey, J; Sutherland, P	1
Fareed, J; Hoppensteadt, D; Racanelli, A; Walenga, JM	1
Buchanan, M; Hirsh, J; Ofosu, F	1
Cade, JF; Magnani, HN; Westlake, GW; Wood, M	1
Buchanan, MR; Fernandez, F; Hirsh, J; N'guyen, P; Ofosu, FA; Van Ryn, J	1
Buchanan, MR; Fernandez, F; Hirsh, J; Ofosu, FA; Van Ryn, J	1
Buchanan, MR; Fernandez, F; Ofosu, FA; Van Ryn, J	1
Büller, HR; Henny, CP; Moulijn, AC; Sie, TH; Ten Cate, H; Ten Cate, JW; Warren, P	1

Reviews

17 review(s) available for dermatan sulfate and Hemorrhage

Article	Year
Argatroban: for a few selected patients. Prescrire international, 2013, Volume: 22, Issue:135 Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Interactions; Drug Substitution; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Patient Selection; Pipecolic Acids; Risk Assessment; Risk Factors; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis	2013
[Heparin-induced thrombocytopenia type II (HIT II) : A medical-economic view]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:4 Topics: Arginine; Chondroitin Sulfates; Costs and Cost Analysis; Dermatan Sulfate; Germany; Hemorrhage; Heparin; Heparitin Sulfate; Hospitalization; Humans; Pipecolic Acids; Risk Factors; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome	2017
An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran). Thrombosis research, 2010, Volume: 125, Issue:4 Topics: Abortion, Spontaneous; Chondroitin Sulfates; Dermatan Sulfate; Exanthema; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Subcutaneous; Pregnancy; Research; Thrombosis; Treatment Outcome	2010
A review of 122 published outcomes of danaparoid anticoagulation for intermittent haemodialysis. Thrombosis research, 2010, Volume: 125, Issue:4 Topics: Chondroitin Sulfates; Dermatan Sulfate; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Platelet Count; Pregnancy; Recurrence; Renal Dialysis; Thrombosis; Treatment Outcome	2010
Treatment of 51 pregnancies with danaparoid because of heparin intolerance. Thrombosis and haemostasis, 2005, Volume: 93, Issue:1 Topics: Adult; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Evaluation; Drug Hypersensitivity; Exanthema; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; MEDLINE; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Retrospective Studies; Thrombocytopenia; Thrombosis	2005
Essentials of anticoagulation in hemodialysis. Hemodialysis international. International Symposium on Home Hemodialysis, 2007, Volume: 11, Issue:2 Topics: Anticoagulants; Arginine; Blood Coagulation; Chondroitin Sulfates; Dermatan Sulfate; Equipment Failure; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Renal Dialysis; Renal Insufficiency, Chronic; Sulfonamides	2007
Heparin induced thrombocytopenia: diagnosis and management update. Postgraduate medical journal, 2007, Volume: 83, Issue:983 Topics: Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin	2007
A comparative review of the adverse effect profiles of heparins and heparinoids. Drug safety, 1995, Volume: 12, Issue:1 Topics: Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparinoids; Heparitin Sulfate; Hip Prosthesis; Humans; Molecular Weight; Postoperative Complications; Thrombocytopenia; Thrombosis; Wound Infection	1995
Pharmacological actions of sulodexide. Seminars in thrombosis and hemostasis, 1998, Volume: 24, Issue:2 Topics: Animals; Anticoagulants; Biological Availability; Blood Coagulation; Carotid Artery Thrombosis; Clinical Trials as Topic; Dermatan Sulfate; Drug Administration Routes; Drug Evaluation, Preclinical; Endothelium, Vascular; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Humans; Molecular Weight; Multicenter Studies as Topic; Myocardial Infarction; Partial Thromboplastin Time; Rabbits; Rats; Thrombosis	1998
Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management. Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3 Topics: Ancrod; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Forecasting; Gangrene; Hemorrhage; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation; Protein C; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin	1999
Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass. Perfusion, 2001, Volume: 16, Issue:5 Topics: Abciximab; Ancrod; Antibodies, Monoclonal; Anticoagulants; Arginine; Cardiopulmonary Bypass; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Factor Xa Inhibitors; Hemodilution; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Immunoglobulin Fab Fragments; Perfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Protamines; Sulfonamides; Thrombocytopenia; Thrombophilia; Thrombosis; Tirofiban; Tyrosine	2001
[New antithrombotic drugs (excluding plasminogen activators]. Archives des maladies du coeur et des vaisseaux, 2001, Volume: 94, Issue:11 Suppl Topics: Anticoagulants; Blood Coagulation; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Hemorrhage; Heparitin Sulfate; Hirudin Therapy; Humans; Platelet Aggregation; Risk Factors; Thromboembolism	2001
Structure and anticoagulant properties of sulfated glycosaminoglycans from primitive Chordates. Anais da Academia Brasileira de Ciencias, 2002, Volume: 74, Issue:1 Topics: Animals; Anticoagulants; Dermatan Sulfate; Glycosaminoglycans; Hemorrhage; Heparin; Heparin Cofactor II; Mammals; Platelet Aggregation; Rats; Urochordata	2002
Orgaran (Org 10172): its pharmacological profile in experimental models. Haemostasis, 1992, Volume: 22, Issue:2 Topics: Animals; Carbohydrate Sequence; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Molecular Sequence Data; Platelet Aggregation; Rabbits; Rats; Thrombin; Thrombolytic Therapy; Thrombosis	1992
Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group. Haemostasis, 1992, Volume: 22, Issue:2 Topics: Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation; Factor Xa Inhibitors; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Incidence; Pilot Projects; Prothrombin; Thrombolytic Therapy; Treatment Outcome; United States	1992
Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan. Seminars in thrombosis and hemostasis, 1991, Volume: 17 Suppl 2 Topics: Animals; Anticoagulants; Blood Coagulation; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Mammals; Molecular Weight; Platelet Aggregation; Postoperative Complications; Rabbits; Renal Dialysis; Thrombocytopenia; Thrombophlebitis; Thrombosis	1991
Rationale behind the development of low molecular weight heparin derivatives. Seminars in thrombosis and hemostasis, 1985, Volume: 11, Issue:1 Topics: Animals; Antithrombin III; Blood Coagulation; Blood Platelets; Dermatan Sulfate; Dose-Response Relationship, Drug; Factor X; Factor Xa; Hemorrhage; Heparin; Humans; Molecular Weight; Pentosan Sulfuric Polyester; Platelet Aggregation; Prothrombin; Structure-Activity Relationship; Sulfates; Thrombosis	1985

Trials

11 trial(s) available for dermatan sulfate and Hemorrhage

Article	Year
Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' Group. Thrombosis and haemostasis, 1993, Oct-18, Volume: 70, Issue:4 Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Elective Surgical Procedures; Female; Gastrointestinal Neoplasms; Glycosaminoglycans; Hematologic Tests; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis	1993
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Annals of internal medicine, 1995, Jul-01, Volume: 123, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Drug Administration Schedule; Drug Combinations; Female; Hemorrhage; Heparin; Heparinoids; Heparitin Sulfate; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Pulmonary Embolism; Thromboembolism; Treatment Outcome	1995
Risk factors for bleeding during treatment of acute venous thromboembolism. Thrombosis and haemostasis, 1996, Volume: 76, Issue:5 Topics: Acenocoumarol; Acute Disease; Adult; Aged; Body Surface Area; Chondroitin Sulfates; Comorbidity; Dermatan Sulfate; Drug Combinations; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Neoplasms; Odds Ratio; Prospective Studies; Risk Factors; Single-Blind Method; Thromboembolism; Thrombolytic Therapy	1996
A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia. Thrombosis and haemostasis, 2001, Volume: 85, Issue:6 Topics: Age Factors; Aged; Amputation, Surgical; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Evaluation; Female; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Incidence; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Surveys and Questionnaires; Thrombocytopenia; Thromboembolism; Treatment Outcome	2001
Orgaran in hip fracture surgery. Haemostasis, 1992, Volume: 22, Issue:2 Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Female; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Hip Fractures; Humans; Incidence; Male; Postoperative Complications; Pulmonary Embolism; Scandinavian and Nordic Countries; Single-Blind Method; Thrombophlebitis; United States; Warfarin	1992
Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group. Haemostasis, 1992, Volume: 22, Issue:2 Topics: Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation; Factor Xa Inhibitors; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Incidence; Pilot Projects; Prothrombin; Thrombolytic Therapy; Treatment Outcome; United States	1992
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Annals of internal medicine, 1992, Sep-01, Volume: 117, Issue:5 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antithrombin III; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Fibrinolytic Agents; Follow-Up Studies; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombophlebitis	1992
Dermatan sulphate: a safe approach to prevention of postoperative deep vein thrombosis. The British journal of surgery, 1992, Volume: 79, Issue:6 Topics: Adult; Aged; Dermatan Sulfate; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Plethysmography, Impedance; Postoperative Complications; Prospective Studies; Thrombophlebitis	1992
Thromboprophylaxis in patients with hip fractures: a prospective, randomized, comparative study between Org 10172 and dextran 70. Surgery, 1991, Volume: 109, Issue:5 Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Female; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Hip Fractures; Humans; Male; Single-Blind Method; Thrombophlebitis	1991
The influence of Org 10172, an antithrombotic heparinoid, on urinary blood loss after transurethral prostatectomy. Thrombosis research, 1989, Oct-15, Volume: 56, Issue:2 Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Glycosaminoglycans; Hematuria; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Prostatectomy; Randomized Controlled Trials as Topic; Thrombophlebitis; Urologic Diseases	1989
Early clinical experience of a new heparinoid, Org 10172, in prevention of deep venous thrombosis. Thrombosis research, 1987, Mar-01, Volume: 45, Issue:5 Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Factor X; Factor Xa; Female; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Pilot Projects; Research Design; Thoracic Surgery; Thrombophlebitis	1987

Other Studies

21 other study(ies) available for dermatan sulfate and Hemorrhage

Article	Year
Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective Analysis. Acta haematologica, 2020, Volume: 143, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Chondroitin Sulfates; Dermatan Sulfate; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Neoplasms; Hemorrhage; Heparitin Sulfate; Humans; Male; Middle Aged; Plasma; Protease Inhibitors; Prothrombin Time; Retrospective Studies; Treatment Outcome	2020
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia. Journal of the American College of Cardiology, 2017, Nov-28, Volume: 70, Issue:21 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Female; Fondaparinux; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Hospital Mortality; Hospitalization; Humans; Male; Necrosis; Off-Label Use; Partial Thromboplastin Time; Patient Safety; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Registries; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome	2017
Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients. Intensive care medicine, 2004, Volume: 30, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Drug Combinations; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Risk Factors; Thrombocytopenia; Venous Thrombosis	2004
Safety and efficacy of danaparoid (Orgaran) use in children. Acta haematologica, 2006, Volume: 115, Issue:3-4 Topics: Adolescent; Adult; Child; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Infant; Infant, Newborn; Male; Purpura, Thrombocytopenic, Idiopathic; Risk Factors; Thrombosis	2006
Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complications. Lancet (London, England), 1983, Apr-23, Volume: 1, Issue:8330 Topics: Acute Kidney Injury; Adult; Aged; Blood Platelet Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation; Female; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk	1983
Is heparin the ideal anticoagulant for cardiopulmonary bypass? Dermatan sulphate may be an alternate choice. Thrombosis and haemostasis, 1994, Volume: 71, Issue:4 Topics: Animals; Blood Coagulation Tests; Blood Loss, Surgical; Cardiopulmonary Bypass; Dermatan Sulfate; Drug Evaluation, Preclinical; Hemorrhage; Heparin; Intraoperative Complications; Swine; Thrombosis	1994
Low affinity heparin is an antithrombotic agent. Thrombosis and haemostasis, 1994, Volume: 71, Issue:2 Topics: Animals; Bleeding Time; Dermatan Sulfate; Disease Models, Animal; Hemorrhage; Heparin; Humans; Metabolic Clearance Rate; Rabbits; Thrombin; Thrombophlebitis	1994
Heparin-induced thrombocytopenia (HIT) and thrombosis in a haemodialysis-dependent patient with systemic vasculitis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:12 Topics: Acute Kidney Injury; Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Lung Diseases; Male; Phlebography; Renal Dialysis; Thrombocytopenia; Venous Thrombosis	1998
Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran). The Annals of thoracic surgery, 1999, Volume: 68, Issue:3 Topics: Anticoagulants; Cardiopulmonary Bypass; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heart Defects, Congenital; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Thrombocytopenia; Thrombosis	1999
Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases. Perfusion, 2000, Volume: 15, Issue:6 Topics: Adult; Aged; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Postoperative Complications; Thrombocytopenia	2000
Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2001, Volume: 7, Issue:4 Topics: Adult; Aged; Anticoagulants; Chondroitin Sulfates; Contraindications; Critical Care; Dermatan Sulfate; Drug Combinations; Drug Evaluation; Female; Hemorrhage; Heparin; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Multiple Organ Failure; Renal Replacement Therapy; Retrospective Studies; Thrombosis; Treatment Outcome	2001
Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding. Thrombosis and haemostasis, 2001, Volume: 86, Issue:5 Topics: Animals; Anticoagulants; Blood Coagulation; Cattle; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Hemorrhage; Heparin Cofactor II; Male; Protein Binding; Rats; Rats, Wistar; Species Specificity; Thrombin; Thrombosis; Urochordata	2001
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparin. Thrombosis research, 1990, Nov-01, Volume: 60, Issue:3 Topics: Animals; Blood Coagulation Tests; Dermatan Sulfate; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Rabbits	1990
Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. Stroke, 1990, Volume: 21, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Humans; Injections, Intravenous; Middle Aged; Pilot Projects	1990
A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke. Neurology, 1989, Volume: 39, Issue:2 Pt 1 Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Molecular Weight	1989
Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental models. Seminars in thrombosis and hemostasis, 1989, Volume: 15, Issue:4 Topics: Animals; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Injections, Intravenous; Injections, Subcutaneous; Rabbits; Rats; Thrombosis	1989
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparin. Seminars in thrombosis and hemostasis, 1989, Volume: 15, Issue:4 Topics: Animals; Blood Coagulation Tests; Chondroitin; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Male; Rabbits; Thrombosis	1989
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. Thrombosis research, 1986, Aug-15, Volume: 43, Issue:4 Topics: Animals; Blood Platelets; Chromium Radioisotopes; Collagen; Dermatan Sulfate; Erythrocytes; Glycosaminoglycans; Hemorrhage; Heparin; Kinetics; Molecular Weight; Platelet Aggregation; Rabbits	1986
The haemorrhagic and antithrombotic effects of dermatan sulphate. British journal of haematology, 1986, Volume: 64, Issue:2 Topics: Animals; Blood Coagulation; Chondroitin; Dermatan Sulfate; Dose-Response Relationship, Drug; Factor X; Factor Xa; Hemorrhage; Heparin; Platelet Aggregation; Rabbits; Thrombosis	1986
Lack of relationship between enhanced bleeding induced by heparin and other sulfated polysaccharides and enhanced catalysis of thrombin inhibition. Seminars in thrombosis and hemostasis, 1986, Volume: 12, Issue:4 Topics: Animals; Dermatan Sulfate; Hemorrhage; Heparin; Polysaccharides; Rabbits; Sulfates; Thrombin	1986
A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs. The Journal of laboratory and clinical medicine, 1985, Volume: 106, Issue:2 Topics: Animals; Antithrombins; Blood Coagulation Tests; Blood Volume; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Dogs; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycosaminoglycans; Hematocrit; Hemorrhage; Heparin; Heparitin Sulfate; Leukocyte Count; Molecular Weight; Platelet Count; Postoperative Complications; Random Allocation	1985